More than 340,000 women lose their lives to cervical cancer each year, yet the global community has the capabilities to eliminate this cancer within our lifetime. While significant access barriers and health inequities pose a challenge, we can help patients get the access they need and bridge these gaps. Early detection with effective screening can help reduce this high mortality rate, which is why BD is advancing products like at-home sample self-collection, helping improve access to vulnerable populations, particularly where health disparities exist. 

In a recent LinkedIn article, Tom Polen, BD Chairman, CEO and President, shares what it will take to fight – and potentially end – cervical cancer.

Read the full article on LinkedIn and be sure to follow Tom for his latest insights.